Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!

 



Forgot your password?
typodupeerror
×
Android Google Java Oracle The Almighty Buck The Courts

Oracle Ordered To Lower Damages Claim On Google 204

CWmike writes "Oracle has been ordered to lower its multibillion-dollar claim for damages in its patent infringement lawsuit against Google and its Android operating system, court papers show. Oracle's expert 'overreached' in concluding that Google owed up to $6.1 billion in damages for alleged infringement of Oracle's Java patents, U.S. District Court Judge William Alsup said Friday in a sternly written order. The 'starting point' for Oracle's damages claim should be $100 million, adjusted up and down for various factors, he said. At the same time, Google was wrong to assert that its advertising revenue is not related to the value of Android and should therefore not be a part of Oracle's damages, the judge wrote. He also warned Google, 'there is a substantial possibility that a permanent injunction will be granted' if it is found guilty of infringement."
This discussion has been archived. No new comments can be posted.

Oracle Ordered To Lower Damages Claim On Google

Comments Filter:
  • by Dunbal ( 464142 ) * on Saturday July 23, 2011 @07:42PM (#36859706)

    Who the heck then will invest for capital intensive research like medicine and semi-conductor fab tech?

    Perhaps you're looking at it backwards. With patents out of the picture, there will be a need to do things much, much cheaper and innovation will drive towards increasing efficiency rather than how to protect your monopoly. I love it when the drug argument is used regarding patents. I just answer sarcastically: yeah, because acetyl salicylic acid (more commonly known as Aspirin) which has been out of patent since forever is a real money-loser. You will never find generic/store brand painkillers containing this product. Here ends the sarcasm. Pharmacy companies complain about all the billions it takes to make a new drug and fail to mention that drugs still sell long after the patents expire. It's not like Lipitor has been pulled from the shelves (patent just expired recently). Yeah there's competition - so what? For every Coke there's a Pepsi, for every McDonalds there's a Burger King. Suck it up and earn your money like everyone else.

  • by cavreader ( 1903280 ) on Saturday July 23, 2011 @08:25PM (#36859894)
    "Just wait for your competitor to do it for you, burning billions in the process, then manufacture it yourself at a cheaper price - you don't have R&D money to recoup - and undercut them to death." This accurately describes China's approach to saving R&D expenses.
  • by JAlexoi ( 1085785 ) on Saturday July 23, 2011 @09:21PM (#36860108) Homepage

    Does Android compete with Oracle? (No, Oracle doesn't market phones or tablets and never will.)

    Oracle licenses Java ME to phone manufacturers and Android is destroying that revenue. Though in a good sense, because Java ME should be killed off.

  • by bigBlackSabbath ( 462796 ) on Saturday July 23, 2011 @09:42PM (#36860184)

    What? Where did that leap in logic come from? Sun had specific terms around using Java in embedded applications. It appears Google realized that, but perhaps felt by using Dalvik rather than a Sun JRE, they would be avoiding that.

    Most mainstream Java programming, involves server-side applications. The outcome of this trial should have no bearing whatsoever on those mainstream uses of Java. At all.

    If Java's mainstream appeal will be diminished by anything, it's the rise of alternatives (e.g., ruby, python, c#, etc.).

    I don't know if you're spreading FUD, you're uninformed, or you just don't like Oracle. Either way, you're speculation strikes me as wild and baseless.

"Look! There! Evil!.. pure and simple, total evil from the Eighth Dimension!" -- Buckaroo Banzai

Working...